FBN1 and ovarian cancer: Similarly, Wang et al. developed 10 pairs of cisplatin-sensitive and resistant ovarian cancer organoids derived from as many patients who underwent cytoreductive surgery aiming to analyze the role of FBN1 in the chemoresistance process in ovarian cancer.